Tobacco Control

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Tobacco Control 2008;17:73-74; doi:10.1136/tc.2008.025106
Copyright © 2008 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Chapman, S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chapman, S.
Topic Collections
Right arrowRelated Article

EDITORIALS

Benefits and risks in ending regulatory exceptionalism for tobacco

Simon Chapman

School of Public Health, University of Sydney, NSW, Australia

Correspondence to:
Professor Simon Chapman, School of Public Health, Edward Ford Building A27, University of Sydney, Sydney, NSW 2006, Australia; sc@med.usyd.edu.au

The first 150 words of the full text of this article appear below.

It has often been noted that the tobacco industry is cosseted by regulatory exceptionalism. Unlike food, drink and pharmaceuticals that are taken into the body, and doctors, dentists, podiatrists, tattooists, body piercers and even brothels whose work involves various gradations of body penetration, tobacco remains the only commercial product or service intended to be taken into the body which is not commonly subject to safety regulation standards. Those wanting to do things to other’s bodies have to be qualified, trained, inspected, tested and risk losing their rights to practice if breaching legislated standards. Drugs designed to save lives and enhance health are subject to elaborate regulatory controls and those selling them required to undertake degrees in pharmacy or medicine. In most nations, tobacco, which causes stratospheric death estimated to reach a billion this century,1 can be sold by anyone. Manufacturers are free to add any licit additive for whatever purpose . . . [Full text of this article]


Related Article

Mandated lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposal
D M Burns, E Dybing, N Gray, S Hecht, C Anderson, T Sanner, R O’Connor, M Djordjevic, C Dresler, P Hainaut, M Jarvis, A Opperhuizen, and K Straif
Tob. Control 2008 17: 132-141. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Tobacco ControlHome page
J. Liberman and M. Heyward
Use of the precautionary principle in the debate about emissions limits: a cautionary note
Tob. Control, August 1, 2008; 17(4): 286 - 287.
[Full Text] [PDF]


Home page
Tobacco ControlHome page
N. Gray
A letter from Nigel Gray
Tob. Control, August 1, 2008; 17(4): 287 - 288.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 by the BMJ Publishing Group Ltd.